Review



diaminobenzidine substrate kit  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Vector Laboratories diaminobenzidine substrate kit
    Diaminobenzidine Substrate Kit, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 11899 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/diaminobenzidine substrate kit/product/Vector Laboratories
    Average 96 stars, based on 11899 article reviews
    diaminobenzidine substrate kit - by Bioz Stars, 2026-04
    96/100 stars

    Images



    Similar Products

    94
    Dojindo Labs diaminobenzidine tetrahydrochloride
    Diaminobenzidine Tetrahydrochloride, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/diaminobenzidine tetrahydrochloride/product/Dojindo Labs
    Average 94 stars, based on 1 article reviews
    diaminobenzidine tetrahydrochloride - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    96
    Vector Laboratories diaminobenzidine substrate kit
    Diaminobenzidine Substrate Kit, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/diaminobenzidine substrate kit/product/Vector Laboratories
    Average 96 stars, based on 1 article reviews
    diaminobenzidine substrate kit - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc signalstain dab substrate kit
    Signalstain Dab Substrate Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/signalstain dab substrate kit/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    signalstain dab substrate kit - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc 3 3 diaminobenzidine dab substrate
    A Schematic of the drug affinity responsive target stability (DARTS) approach. B Western blotting of candidate proteins in replicatively senescent human dermal fibroblasts. Replicatively senescent human visceral preadipocytes (RS HPAs) were transfected with siRNA, incubated for 4 days, then treated with homoharringtonine (HHT) or phosphate buffered saline (PBS) for 4 days ( C–E ). C Cell number by CCK-8 assay ( n = 7 per group). D Immunoblots of poly (ADP-ribose) polymerase (PARP), procaspase-3 (Procasp-3) and cleaved casp-3 (Casp-3). E Quantification of Casp-3 ( n = 3 per group). F Cell number by CCK-8 assay in HSPA5-overexpressing HPAs ( n = 4 per group). G IHC images and quantification of HSPA5 (brown) and Casp-3 (red) in NS and RS HPAs after 2-day HHT treatment ( n = 6 fields from 2 independent experiments). Boxed region enlarged and split into HSPA5 (brown) and Casp-3 (red) channels. H Quantification of Casp-3-positive cells in HHT-treated RS HPAs with high or low HSPA5 ( n = 6 fields from 2 experiments). I Levels of HSPA5, p53, p21, and p16 proteins in HPAs at different passages. J HHT dose-response curves in HPAs at different passages (Low, P2–P3; Mid, P6–P7; High, P12–P13) (n = 5 per group). K Surface plasmon resonance affinity assay. L Predicted HHT–HSPA5 binding; H-bonds (magenta) and pi–cation (blue). M Inhibition of ATPase activity of HSPA5 by HHT and by HA15 ( n = 3 per group). N HSPA5 levels in adipose tissues of chow diet (Ch)- and high-fat diet (HF)-fed mice administered PBS or HHT ( n = 3 in Ch; n = 5 in HF). O IHC images and quantification of HSPA5 in adipose tissue of Ch- and HF-fed mice administered PBS or HHT ( n = 3 per group). P HSPA5 in adipose tissues of aged mice administered PBS or HHT ( n = 4 per group). Data are expressed as means ± SEM and analyzed via one-way ANOVA with a post-hoc test or two-tailed Student’s t test. DAB, <t>3,3′-diaminobenzidine;</t> GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HSPA5, heat shock protein family A member 5; HSPA8, heat shock protein family A member 8; PKM2, pyruvate kinase M2; RPL7, ribosomal protein L7; siSC, scrambled siRNA; TXNRD1, thioredoxin reductase 1. Illustration created in part (A) with BioRender ( https://BioRender.com/02ykozw ).
    3 3 Diaminobenzidine Dab Substrate, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/3 3 diaminobenzidine dab substrate/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    3 3 diaminobenzidine dab substrate - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    94
    Beyotime beyoclick edu 594 cell proliferation assay kit
    A Schematic of the drug affinity responsive target stability (DARTS) approach. B Western blotting of candidate proteins in replicatively senescent human dermal fibroblasts. Replicatively senescent human visceral preadipocytes (RS HPAs) were transfected with siRNA, incubated for 4 days, then treated with homoharringtonine (HHT) or phosphate buffered saline (PBS) for 4 days ( C–E ). C Cell number by CCK-8 assay ( n = 7 per group). D Immunoblots of poly (ADP-ribose) polymerase (PARP), procaspase-3 (Procasp-3) and cleaved casp-3 (Casp-3). E Quantification of Casp-3 ( n = 3 per group). F Cell number by CCK-8 assay in HSPA5-overexpressing HPAs ( n = 4 per group). G IHC images and quantification of HSPA5 (brown) and Casp-3 (red) in NS and RS HPAs after 2-day HHT treatment ( n = 6 fields from 2 independent experiments). Boxed region enlarged and split into HSPA5 (brown) and Casp-3 (red) channels. H Quantification of Casp-3-positive cells in HHT-treated RS HPAs with high or low HSPA5 ( n = 6 fields from 2 experiments). I Levels of HSPA5, p53, p21, and p16 proteins in HPAs at different passages. J HHT dose-response curves in HPAs at different passages (Low, P2–P3; Mid, P6–P7; High, P12–P13) (n = 5 per group). K Surface plasmon resonance affinity assay. L Predicted HHT–HSPA5 binding; H-bonds (magenta) and pi–cation (blue). M Inhibition of ATPase activity of HSPA5 by HHT and by HA15 ( n = 3 per group). N HSPA5 levels in adipose tissues of chow diet (Ch)- and high-fat diet (HF)-fed mice administered PBS or HHT ( n = 3 in Ch; n = 5 in HF). O IHC images and quantification of HSPA5 in adipose tissue of Ch- and HF-fed mice administered PBS or HHT ( n = 3 per group). P HSPA5 in adipose tissues of aged mice administered PBS or HHT ( n = 4 per group). Data are expressed as means ± SEM and analyzed via one-way ANOVA with a post-hoc test or two-tailed Student’s t test. DAB, <t>3,3′-diaminobenzidine;</t> GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HSPA5, heat shock protein family A member 5; HSPA8, heat shock protein family A member 8; PKM2, pyruvate kinase M2; RPL7, ribosomal protein L7; siSC, scrambled siRNA; TXNRD1, thioredoxin reductase 1. Illustration created in part (A) with BioRender ( https://BioRender.com/02ykozw ).
    Beyoclick Edu 594 Cell Proliferation Assay Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/beyoclick edu 594 cell proliferation assay kit/product/Beyotime
    Average 94 stars, based on 1 article reviews
    beyoclick edu 594 cell proliferation assay kit - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc dab substrate kit
    A Schematic of the drug affinity responsive target stability (DARTS) approach. B Western blotting of candidate proteins in replicatively senescent human dermal fibroblasts. Replicatively senescent human visceral preadipocytes (RS HPAs) were transfected with siRNA, incubated for 4 days, then treated with homoharringtonine (HHT) or phosphate buffered saline (PBS) for 4 days ( C–E ). C Cell number by CCK-8 assay ( n = 7 per group). D Immunoblots of poly (ADP-ribose) polymerase (PARP), procaspase-3 (Procasp-3) and cleaved casp-3 (Casp-3). E Quantification of Casp-3 ( n = 3 per group). F Cell number by CCK-8 assay in HSPA5-overexpressing HPAs ( n = 4 per group). G IHC images and quantification of HSPA5 (brown) and Casp-3 (red) in NS and RS HPAs after 2-day HHT treatment ( n = 6 fields from 2 independent experiments). Boxed region enlarged and split into HSPA5 (brown) and Casp-3 (red) channels. H Quantification of Casp-3-positive cells in HHT-treated RS HPAs with high or low HSPA5 ( n = 6 fields from 2 experiments). I Levels of HSPA5, p53, p21, and p16 proteins in HPAs at different passages. J HHT dose-response curves in HPAs at different passages (Low, P2–P3; Mid, P6–P7; High, P12–P13) (n = 5 per group). K Surface plasmon resonance affinity assay. L Predicted HHT–HSPA5 binding; H-bonds (magenta) and pi–cation (blue). M Inhibition of ATPase activity of HSPA5 by HHT and by HA15 ( n = 3 per group). N HSPA5 levels in adipose tissues of chow diet (Ch)- and high-fat diet (HF)-fed mice administered PBS or HHT ( n = 3 in Ch; n = 5 in HF). O IHC images and quantification of HSPA5 in adipose tissue of Ch- and HF-fed mice administered PBS or HHT ( n = 3 per group). P HSPA5 in adipose tissues of aged mice administered PBS or HHT ( n = 4 per group). Data are expressed as means ± SEM and analyzed via one-way ANOVA with a post-hoc test or two-tailed Student’s t test. DAB, <t>3,3′-diaminobenzidine;</t> GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HSPA5, heat shock protein family A member 5; HSPA8, heat shock protein family A member 8; PKM2, pyruvate kinase M2; RPL7, ribosomal protein L7; siSC, scrambled siRNA; TXNRD1, thioredoxin reductase 1. Illustration created in part (A) with BioRender ( https://BioRender.com/02ykozw ).
    Dab Substrate Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dab substrate kit/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    dab substrate kit - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    99
    Qiagen 74104 dab enhanced liquid substrate system sigma aldrich cat
    A Schematic of the drug affinity responsive target stability (DARTS) approach. B Western blotting of candidate proteins in replicatively senescent human dermal fibroblasts. Replicatively senescent human visceral preadipocytes (RS HPAs) were transfected with siRNA, incubated for 4 days, then treated with homoharringtonine (HHT) or phosphate buffered saline (PBS) for 4 days ( C–E ). C Cell number by CCK-8 assay ( n = 7 per group). D Immunoblots of poly (ADP-ribose) polymerase (PARP), procaspase-3 (Procasp-3) and cleaved casp-3 (Casp-3). E Quantification of Casp-3 ( n = 3 per group). F Cell number by CCK-8 assay in HSPA5-overexpressing HPAs ( n = 4 per group). G IHC images and quantification of HSPA5 (brown) and Casp-3 (red) in NS and RS HPAs after 2-day HHT treatment ( n = 6 fields from 2 independent experiments). Boxed region enlarged and split into HSPA5 (brown) and Casp-3 (red) channels. H Quantification of Casp-3-positive cells in HHT-treated RS HPAs with high or low HSPA5 ( n = 6 fields from 2 experiments). I Levels of HSPA5, p53, p21, and p16 proteins in HPAs at different passages. J HHT dose-response curves in HPAs at different passages (Low, P2–P3; Mid, P6–P7; High, P12–P13) (n = 5 per group). K Surface plasmon resonance affinity assay. L Predicted HHT–HSPA5 binding; H-bonds (magenta) and pi–cation (blue). M Inhibition of ATPase activity of HSPA5 by HHT and by HA15 ( n = 3 per group). N HSPA5 levels in adipose tissues of chow diet (Ch)- and high-fat diet (HF)-fed mice administered PBS or HHT ( n = 3 in Ch; n = 5 in HF). O IHC images and quantification of HSPA5 in adipose tissue of Ch- and HF-fed mice administered PBS or HHT ( n = 3 per group). P HSPA5 in adipose tissues of aged mice administered PBS or HHT ( n = 4 per group). Data are expressed as means ± SEM and analyzed via one-way ANOVA with a post-hoc test or two-tailed Student’s t test. DAB, <t>3,3′-diaminobenzidine;</t> GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HSPA5, heat shock protein family A member 5; HSPA8, heat shock protein family A member 8; PKM2, pyruvate kinase M2; RPL7, ribosomal protein L7; siSC, scrambled siRNA; TXNRD1, thioredoxin reductase 1. Illustration created in part (A) with BioRender ( https://BioRender.com/02ykozw ).
    74104 Dab Enhanced Liquid Substrate System Sigma Aldrich Cat, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/74104 dab enhanced liquid substrate system sigma aldrich cat/product/Qiagen
    Average 99 stars, based on 1 article reviews
    74104 dab enhanced liquid substrate system sigma aldrich cat - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc disease cst cell signaling technology dss dextran sulfate sodium dab diaminobenzidine ecl enhanced chemiluminescence go gene ontology h e hematoxylin
    A Schematic of the drug affinity responsive target stability (DARTS) approach. B Western blotting of candidate proteins in replicatively senescent human dermal fibroblasts. Replicatively senescent human visceral preadipocytes (RS HPAs) were transfected with siRNA, incubated for 4 days, then treated with homoharringtonine (HHT) or phosphate buffered saline (PBS) for 4 days ( C–E ). C Cell number by CCK-8 assay ( n = 7 per group). D Immunoblots of poly (ADP-ribose) polymerase (PARP), procaspase-3 (Procasp-3) and cleaved casp-3 (Casp-3). E Quantification of Casp-3 ( n = 3 per group). F Cell number by CCK-8 assay in HSPA5-overexpressing HPAs ( n = 4 per group). G IHC images and quantification of HSPA5 (brown) and Casp-3 (red) in NS and RS HPAs after 2-day HHT treatment ( n = 6 fields from 2 independent experiments). Boxed region enlarged and split into HSPA5 (brown) and Casp-3 (red) channels. H Quantification of Casp-3-positive cells in HHT-treated RS HPAs with high or low HSPA5 ( n = 6 fields from 2 experiments). I Levels of HSPA5, p53, p21, and p16 proteins in HPAs at different passages. J HHT dose-response curves in HPAs at different passages (Low, P2–P3; Mid, P6–P7; High, P12–P13) (n = 5 per group). K Surface plasmon resonance affinity assay. L Predicted HHT–HSPA5 binding; H-bonds (magenta) and pi–cation (blue). M Inhibition of ATPase activity of HSPA5 by HHT and by HA15 ( n = 3 per group). N HSPA5 levels in adipose tissues of chow diet (Ch)- and high-fat diet (HF)-fed mice administered PBS or HHT ( n = 3 in Ch; n = 5 in HF). O IHC images and quantification of HSPA5 in adipose tissue of Ch- and HF-fed mice administered PBS or HHT ( n = 3 per group). P HSPA5 in adipose tissues of aged mice administered PBS or HHT ( n = 4 per group). Data are expressed as means ± SEM and analyzed via one-way ANOVA with a post-hoc test or two-tailed Student’s t test. DAB, <t>3,3′-diaminobenzidine;</t> GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HSPA5, heat shock protein family A member 5; HSPA8, heat shock protein family A member 8; PKM2, pyruvate kinase M2; RPL7, ribosomal protein L7; siSC, scrambled siRNA; TXNRD1, thioredoxin reductase 1. Illustration created in part (A) with BioRender ( https://BioRender.com/02ykozw ).
    Disease Cst Cell Signaling Technology Dss Dextran Sulfate Sodium Dab Diaminobenzidine Ecl Enhanced Chemiluminescence Go Gene Ontology H E Hematoxylin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/disease cst cell signaling technology dss dextran sulfate sodium dab diaminobenzidine ecl enhanced chemiluminescence go gene ontology h e hematoxylin/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    disease cst cell signaling technology dss dextran sulfate sodium dab diaminobenzidine ecl enhanced chemiluminescence go gene ontology h e hematoxylin - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    Image Search Results


    A Schematic of the drug affinity responsive target stability (DARTS) approach. B Western blotting of candidate proteins in replicatively senescent human dermal fibroblasts. Replicatively senescent human visceral preadipocytes (RS HPAs) were transfected with siRNA, incubated for 4 days, then treated with homoharringtonine (HHT) or phosphate buffered saline (PBS) for 4 days ( C–E ). C Cell number by CCK-8 assay ( n = 7 per group). D Immunoblots of poly (ADP-ribose) polymerase (PARP), procaspase-3 (Procasp-3) and cleaved casp-3 (Casp-3). E Quantification of Casp-3 ( n = 3 per group). F Cell number by CCK-8 assay in HSPA5-overexpressing HPAs ( n = 4 per group). G IHC images and quantification of HSPA5 (brown) and Casp-3 (red) in NS and RS HPAs after 2-day HHT treatment ( n = 6 fields from 2 independent experiments). Boxed region enlarged and split into HSPA5 (brown) and Casp-3 (red) channels. H Quantification of Casp-3-positive cells in HHT-treated RS HPAs with high or low HSPA5 ( n = 6 fields from 2 experiments). I Levels of HSPA5, p53, p21, and p16 proteins in HPAs at different passages. J HHT dose-response curves in HPAs at different passages (Low, P2–P3; Mid, P6–P7; High, P12–P13) (n = 5 per group). K Surface plasmon resonance affinity assay. L Predicted HHT–HSPA5 binding; H-bonds (magenta) and pi–cation (blue). M Inhibition of ATPase activity of HSPA5 by HHT and by HA15 ( n = 3 per group). N HSPA5 levels in adipose tissues of chow diet (Ch)- and high-fat diet (HF)-fed mice administered PBS or HHT ( n = 3 in Ch; n = 5 in HF). O IHC images and quantification of HSPA5 in adipose tissue of Ch- and HF-fed mice administered PBS or HHT ( n = 3 per group). P HSPA5 in adipose tissues of aged mice administered PBS or HHT ( n = 4 per group). Data are expressed as means ± SEM and analyzed via one-way ANOVA with a post-hoc test or two-tailed Student’s t test. DAB, 3,3′-diaminobenzidine; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HSPA5, heat shock protein family A member 5; HSPA8, heat shock protein family A member 8; PKM2, pyruvate kinase M2; RPL7, ribosomal protein L7; siSC, scrambled siRNA; TXNRD1, thioredoxin reductase 1. Illustration created in part (A) with BioRender ( https://BioRender.com/02ykozw ).

    Journal: Nature Communications

    Article Title: Homoharringtonine exhibits senotherapeutic activity that mitigates diet- and age-associated obesity and insulin resistance and extends lifespan in mice

    doi: 10.1038/s41467-026-70475-3

    Figure Lengend Snippet: A Schematic of the drug affinity responsive target stability (DARTS) approach. B Western blotting of candidate proteins in replicatively senescent human dermal fibroblasts. Replicatively senescent human visceral preadipocytes (RS HPAs) were transfected with siRNA, incubated for 4 days, then treated with homoharringtonine (HHT) or phosphate buffered saline (PBS) for 4 days ( C–E ). C Cell number by CCK-8 assay ( n = 7 per group). D Immunoblots of poly (ADP-ribose) polymerase (PARP), procaspase-3 (Procasp-3) and cleaved casp-3 (Casp-3). E Quantification of Casp-3 ( n = 3 per group). F Cell number by CCK-8 assay in HSPA5-overexpressing HPAs ( n = 4 per group). G IHC images and quantification of HSPA5 (brown) and Casp-3 (red) in NS and RS HPAs after 2-day HHT treatment ( n = 6 fields from 2 independent experiments). Boxed region enlarged and split into HSPA5 (brown) and Casp-3 (red) channels. H Quantification of Casp-3-positive cells in HHT-treated RS HPAs with high or low HSPA5 ( n = 6 fields from 2 experiments). I Levels of HSPA5, p53, p21, and p16 proteins in HPAs at different passages. J HHT dose-response curves in HPAs at different passages (Low, P2–P3; Mid, P6–P7; High, P12–P13) (n = 5 per group). K Surface plasmon resonance affinity assay. L Predicted HHT–HSPA5 binding; H-bonds (magenta) and pi–cation (blue). M Inhibition of ATPase activity of HSPA5 by HHT and by HA15 ( n = 3 per group). N HSPA5 levels in adipose tissues of chow diet (Ch)- and high-fat diet (HF)-fed mice administered PBS or HHT ( n = 3 in Ch; n = 5 in HF). O IHC images and quantification of HSPA5 in adipose tissue of Ch- and HF-fed mice administered PBS or HHT ( n = 3 per group). P HSPA5 in adipose tissues of aged mice administered PBS or HHT ( n = 4 per group). Data are expressed as means ± SEM and analyzed via one-way ANOVA with a post-hoc test or two-tailed Student’s t test. DAB, 3,3′-diaminobenzidine; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HSPA5, heat shock protein family A member 5; HSPA8, heat shock protein family A member 8; PKM2, pyruvate kinase M2; RPL7, ribosomal protein L7; siSC, scrambled siRNA; TXNRD1, thioredoxin reductase 1. Illustration created in part (A) with BioRender ( https://BioRender.com/02ykozw ).

    Article Snippet: Following final TBS-T washes, color development was performed using enzyme-specific substrate systems: HRP activity was visualized with 3,3′-diaminobenzidine (DAB) substrate (Cell Signaling Technology, #7076, or Dako, K5007) to yield brown staining, and AP activity was visualized with Fast Red TR/Naphthol AS-MX (Sigma-Aldrich, F4648) to yield red staining.

    Techniques: Western Blot, Transfection, Incubation, Saline, CCK-8 Assay, SPR Assay, Binding Assay, Inhibition, Activity Assay, Two Tailed Test